Treating head and neck cancer in the age of immunotherapy: a 2023 update

A Bhatia, B Burtness - Drugs, 2023 - Springer
Most patients diagnosed with head and neck squamous cell carcinoma (HNSCC) will
present with locally advanced disease, requiring multimodality therapy. While this approach …

Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis

MA O'rorke, MV Ellison, LJ Murray, M Moran, J James… - Oral oncology, 2012 - Elsevier
Human Papillomavirus (HPV) related oropharyngeal squamous cell carcinomas (OPSCCs)
are reported to have improved prognosis and survival in comparison to other head and neck …

Management of the neck in squamous cell carcinoma of the oral cavity and oropharynx: ASCO clinical practice guideline

SA Koyfman, N Ismaila, D Crook, A D'Cruz… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE The aim of the current work is to provide evidence-based recommendations to
practicing physicians and others on the management of the neck in patients with squamous …

[HTML][HTML] Oral cancer: Current role of radiotherapy and chemotherapy

SH Huang - Medicina oral, patologia oral y cirugia bucal, 2013 - ncbi.nlm.nih.gov
The term oral cavity cancer (OSCC) constitutes cancers of the mucosal surfaces of the lips,
floor of mouth, oral tongue, buccal mucosa, lower and upper gingiva, hard palate and …

Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions

T Walsh, R Macey, AR Kerr, MW Lingen… - Cochrane Database …, 2021 - cochranelibrary.com
Background Squamous cell carcinoma is the most common form of malignancy of the oral
cavity, and is often proceeded by oral potentially malignant disorders (OPMD). Early …

Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy

S Furness, AM Glenny, HV Worthington… - Cochrane Database …, 2011 - cochranelibrary.com
Background Oral cavity and oropharyngeal cancers are frequently described as part of a
group of oral cancers or head and neck cancer. Treatment of oral cavity cancer is generally …

Head and neck squamous cell carcinoma: risk factors, molecular alterations, immunology and peptide vaccines

Z Sun, X Sun, Z Chen, J Du, Y Wu - International Journal of Peptide …, 2022 - Springer
Head and neck squamous cell carcinoma (HNSCC) arises from the epithelial lining of the
oral cavity, hypopharynx, oropharynx, and larynx. There are several potential risk factors that …

Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults

T Walsh, JLY Liu, P Brocklehurst… - Cochrane Database …, 2013 - cochranelibrary.com
Background The early detection and excision of potentially malignant disorders (PMD) of the
lip and oral cavity that require intervention may reduce malignant transformations (though …

A meta-analysis of margin size and local recurrence in oral squamous cell carcinoma

CR Anderson, K Sisson, M Moncrieff - Oral oncology, 2015 - Elsevier
Objectives: Excision margins for oral squamous cell carcinoma (OSCC) are poorly
understood. Close (< 5 mm) and involved (< 1 mm) pathological margins are key indicators …

Selective neck dissection in surgically treated head and neck squamous cell carcinoma patients with a clinically positive neck: Systematic review

JP Rodrigo, G Grilli, JP Shah, JE Medina… - European Journal of …, 2018 - Elsevier
Adequate treatment of lymph node metastases is essential for patients with head and neck
squamous cell carcinoma (HNSCC). However, there is still no consensus on the optimal …